U.S. Personal Products Stock News

DENTSPLY SIRONA (XRAY) just shook up its finance leadership by naming veteran executive Michael Pomeroy as interim CFO while it continues searching for a permanent hire, a move investors tend to watch closely. See our latest analysis for DENTSPLY SIRONA. The leadership shake up comes at a tough time, with a steep year to date share price return decline alongside a three year total shareholder return that signals momentum has been fading rather than building. If this kind of transition has you...

BioMarin Pharmaceutical (BMRN) just posted its sixth straight quarter of beating Wall Street expectations, with Q2 earnings up roughly 124% year over year after its 2024 restructuring started lifting margins. See our latest analysis for BioMarin Pharmaceutical. Yet despite that earnings momentum, BioMarin’s 2025 year to date share price return is about minus 19 percent and its 1 year total shareholder return is similarly weak. This suggests sentiment has lagged improving fundamentals and...

Duke Energy (DUK) just spotlighted its community focus with nearly $275,000 in surprise microgrants to South Carolina hunger relief groups, part of a broader $600,000 campaign, and investors are asking what this means for the stock. See our latest analysis for Duke Energy. Despite the charitable spotlight, Duke Energy’s recent share price return has eased back, with the stock down over the past month but still posting a positive year to date gain. Multi year total shareholder returns suggest...

Oscar Health (OSCR) just caught traders attention after a wave of bullish options activity and a fresh analyst upgrade, which has put its structural strengths and long term growth story back in focus. See our latest analysis for Oscar Health. Those bullish options bets and the upgrade are landing just as Oscar’s 2025 year to date share price return of 26.79% builds on a massive three year total shareholder return of 527.01%. This suggests momentum is pausing rather than breaking. If Oscar’s...

Netskope (NTSK) just rolled out new security features for Model Context Protocol traffic inside its Netskope One platform, a timely move as more enterprises plug AI agents directly into sensitive internal systems. See our latest analysis for Netskope. The new MCP protections land as Netskope’s 1 day share price return of 7.36 percent and 7 day share price return of 10.75 percent contrast with a weaker year to date share price return of negative 12.49 percent. This suggests short term momentum...

Fresh coverage has put StoneCo (STNE) back on investors radar, spotlighting its value credentials and expanding role in Brazil’s digital payments ecosystem at a time when the stock has pulled back in the past month. See our latest analysis for StoneCo. That pullback sits against a powerful backdrop, with the share price still showing a strong year to date share price return and a robust one year total shareholder return that signals momentum cooling, not collapsing, after a big run. If...

Academy Sports and Outdoors (ASO) just refreshed its board, adding former Walmart US finance chief Michael Dastugue, Habit Burger & Grill CEO Shannon Hennessy, and technology veteran Clay Johnson, a move investors are watching for its strategic implications. See our latest analysis for Academy Sports and Outdoors. The timing of these appointments comes as Academy’s share price has slipped year to date, with a negative year to date share price return but a resilient five year total shareholder...

Enliven Therapeutics (ELVN) has quietly outperformed the broader biotech space over the past month, climbing about 13% as investors revisit its early stage oncology pipeline and the cash runway behind it. See our latest analysis for Enliven Therapeutics. That latest move takes Enliven’s share price to about $21.40, and while the 1 month share price return of roughly 12.6% contrasts with a still negative year to date share price return, it suggests momentum may be starting to rebuild as...

In early December 2025, Albertsons Companies launched its Albertsons AI shopping assistant across all banner websites, using OpenAI-powered, multi-agent technology to help customers plan meals, restock essentials, convert recipes and lists into carts, and complete end-to-end online grocery shopping in minutes. This move signals Albertsons’ push into agentic commerce, laying groundwork for future capabilities like budget optimization, in-store product guidance, and voice-driven shopping that...

IDEX Corporation has announced that Sean M. Gillen will become Senior Vice President and Chief Financial Officer on January 5, 2026, at which point interim CFO Akhil Mahendra will return to his role leading corporate development. The simultaneous CFO transition and planned external hire for a new Chief Human Resources Officer signal a renewed emphasis on capital allocation, portfolio management, and talent strategy across the organization. Next, we’ll examine how appointing Sean Gillen as...

Brookfield Infrastructure Partners (NYSE:BIP) just refreshed its buyback playbook, securing approval to repurchase up to 5% of its LP units and 10% of certain preferred series through late 2026, with all repurchased securities cancelled. See our latest analysis for Brookfield Infrastructure Partners. The backdrop here is a unit price that has quietly regained its footing, with a 30 day share price return of 5.1% and a 90 day share price return of 17.4%. At the same time, the 1 year total...

Westinghouse Air Brake Technologies (Wabtec) recently reported quarterly results showing 8.4% year-on-year revenue growth and adjusted operating income above analyst expectations, despite organic revenue coming in below forecasts. Management’s emphasis on broad-based gains in backlog, sales, margins, and earnings highlights strengthening fundamentals that may influence how investors assess its long-term rail exposure. We’ll now examine how this combination of revenue growth and margin...

Amneal Pharmaceuticals (AMRX) just picked up two meaningful FDA wins, securing approvals for generic versions of Restasis and ProAir HFA that open doors into multibillion dollar ophthalmic and respiratory markets. See our latest analysis for Amneal Pharmaceuticals. Those FDA wins help explain why, despite a softer 1 day share price return of minus 1.97 percent and a 7 day share price return of minus 4.63 percent, Amneal still boasts a 90 day share price return of 24.12 percent and a powerful...

QuidelOrtho (QDEL) is back on investors radar after a fresh round of insider buying, with both a director and the CEO adding to their positions and giving traders a reason to revisit the stock. See our latest analysis for QuidelOrtho. Even with the fresh insider confidence and upcoming healthcare conference appearances, QuidelOrtho's recent 1 month share price return of around 1.6 percent sits against a sharply negative year to date move. This suggests long term momentum is still rebuilding...

Willis Towers Watson (WTW) just rolled out Radar Fusion, a cloud based underwriting platform that uses real time analytics and automation to help commercial insurers handle complex risks more efficiently. See our latest analysis for Willis Towers Watson. While Radar Fusion adds another tech edge to Willis Towers Watson, the share price has moved more steadily, with a modest positive year to date share price return and strong three and five year total shareholder returns suggesting long term...

In early December 2025, Columbia Sportswear released The Endor™ Collection, a 20-piece Star Wars™-inspired lineup that combines its performance outerwear technologies with detailed designs based on the Rebel Alliance’s Endor mission from Return of the Jedi™. By blending fandom-driven storytelling elements, like Aurebesh “easter eggs,” Endor coordinates, and Rebel insignias, with a high-profile campaign fronted by Billie Lourd, Columbia is aiming to deepen engagement with both outdoor...

Scholar Rock Holding (SRRK) is back in the spotlight after its manufacturing partner, Catalent Indiana, received an FDA warning letter. This has raised fresh questions about apitegromab’s launch timing and the stock’s risk reward setup. See our latest analysis for Scholar Rock Holding. Despite the manufacturing overhang and a high profile hedge fund exit, investors have mostly treated these as execution risks rather than a broken thesis. Scholar Rock’s roughly 61 percent 1 month share price...

Oculis Holding AG has closed its previously filed shelf registration dated 10 November 2025, covering US$9.39 million of ordinary shares totaling 494,259 securities. This completed shelf registration, alongside the vesting of restricted stock units for a company director, highlights both Oculis’s evolving capital structure and its approach to equity-based compensation. We’ll now explore how the completion of this US$9.39 million shelf registration shapes Oculis’s investment narrative and...

In late November 2025, PTC Therapeutics was added to the S&P 1000, S&P Composite 1500, S&P 600, and S&P 600 Health Care indices, while also approving new employee inducement equity grants and recording insider share sales by its CEO and a board director. This cluster of index inclusions, insider transactions, and equity awards comes shortly after PTC reported a profitable third quarter and early commercial momentum for its new rare-disease drug Sephience. We’ll now examine how PTC’s broad...

CTS (CTS) has been quietly grinding higher over the past month, even as its year to date return remains negative, which sets up an interesting risk reward picture for investors watching this industrial tech name. See our latest analysis for CTS. At around $44.33, the recent 30 day share price return of 5.67 percent sits awkwardly against a year to date share price decline of 14.57 percent, while the five year total shareholder return of 39.14 percent suggests longer term momentum is still...

UMH Properties (UMH) just folded seven manufactured home communities, totaling 1,765 sites, into its Fannie Mae credit facility, unlocking about $91.8 million in fresh, fixed-rate capital through a nine year, interest only loan. See our latest analysis for UMH Properties. The move comes after a tough stretch for the stock, with the share price down about 19 percent year to date even as the 5 year total shareholder return remains positive at roughly 27 percent. Investors will be watching...

CAVA Group recently reported a 20% year-over-year revenue increase, 1.9% same-restaurant sales growth, and 17 new restaurant openings in its fiscal third quarter, while also being placed on an “upside 90-day catalyst watch” tied to the U.S. government’s reopening. Alongside this expansion, CAVA launched “The CAVA Shop” merch store to broaden revenue sources and deepen brand engagement amid ongoing macroeconomic challenges. We’ll now look at how CAVA’s rapid restaurant expansion and...

In recent days, Goldman Sachs initiated coverage on Joby Aviation with a Sell rating, highlighting concerns around the company’s high valuation, regulatory hurdles and capital-intensive operator model despite its lead in eVTOL certification and growing international test operations. At the same time, Joby has been expanding real-world flight activity in the UAE and pursuing new test facilities in California, underscoring the tension between its operational progress and increasing analyst...

Earlier this week, WisdomTree, Inc. launched the WisdomTree Equity Premium Income Digital Fund, a tokenized vehicle for retail and institutional investors that seeks to track the Volos U.S. Large Cap Target 2.5% PutWrite Index via its WisdomTree Prime and WisdomTree Connect platforms. This launch highlights WisdomTree’s push to combine long-used put-writing income strategies with blockchain-based, tokenized fund structures aimed at crypto-native investors and institutions. We’ll now examine...